ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,504Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 70

$666K Total Retail Price of All Prescriptions

Rank: 17 out of 70

713 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 713 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

11% of this provider’s 713 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,742 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 703 676 1 1
CARVEDILOL 420 403 2 19
LISINOPRIL 411 384 3 3
LEVOTHYROXINE SODIUM 327 303 4 2
FUROSEMIDE 306 277 5 6
AMLODIPINE BESYLATE 303 256 6 5
METOPROLOL SUCCINATE 294 267 7 25
METFORMIN HCL 278 235 8 9
HYDROCHLOROTHIAZIDE 248 228 9 15
OMEPRAZOLE 231 203 10 4
HYDROCODONE-ACETAMINOPHEN 218 186 S3 11 8
POTASSIUM CHLORIDE 216 188 12 12
METOPROLOL TARTRATE 208 186 13 7
LOSARTAN POTASSIUM 182 157 14 24
PANTOPRAZOLE SODIUM 167 143 15 42
ZOLPIDEM TARTRATE 166 121 16 23
ATORVASTATIN CALCIUM 165 155 17 27
SERTRALINE HCL 155 148 18 22
DONEPEZIL HCL 144 141 19 11
DIOVAN 123 109 20 44
GABAPENTIN 119 96 21 14
ALENDRONATE SODIUM 118 110 22 28
CLOPIDOGREL 117 104 23 30
ENALAPRIL MALEATE 116 104 24 54
SPIRONOLACTONE 115 111 25 61
TAMSULOSIN HCL 111 108 26 29
PREDNISONE 105 101 27 52
ISOSORBIDE MONONITRATE ER 95 91 28 50
WARFARIN SODIUM 94 89 29 10
CITALOPRAM HBR 93 81 30 16
TRIAMTERENE-HCTZ 92 89 31 81
MIRTAZAPINE 91 91 32 20
ATENOLOL 91 87 32 21
NEXIUM 87 65 34 63
ADVAIR DISKUS 83 75 35 55
IBUPROFEN 79 29 36 72
ALLOPURINOL 79 76 36 31
LOVASTATIN 77 70 38 33
PLAVIX 76 72 39 43
ROPINIROLE HCL 75 58 40 106
METFORMIN HCL ER 73 73 41 132
PRAVASTATIN SODIUM 72 69 42 18
GLIPIZIDE 71 55 43 48
BENAZEPRIL HCL 71 57 43 111
NAMENDA 71 71 43 13
MELOXICAM 67 54 46 39
CLONIDINE HCL 67 57 46 46
TRAMADOL HCL 66 50 48 17
CIPROFLOXACIN HCL 60 46 49 51
FLUOXETINE HCL 60 45 49 95
GLIPIZIDE XL 59 59 51 292
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 44 52 58
MECLIZINE HCL 57 46 52 115
CRESTOR 56 46 54 45
RANITIDINE HCL 56 47 54 26
MONTELUKAST SODIUM 54 42 56 127
CHLORTHALIDONE 51 45 57 174
GLIPIZIDE ER 51 49 57 204
JANTOVEN 50 50 59 215
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.